KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization Amortization Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2016 - 2025)

Bausch Health Companies' Asset Writedowns and Impairment history spans 12 years, with the latest figure at $7.0 million for Q4 2025.

On a quarterly basis, Asset Writedowns and Impairment fell 69.57% to $7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.0 million, a 72.41% decrease, with the full-year FY2025 number at $8.0 million, down 72.41% from a year prior.
Asset Writedowns and Impairment hit $7.0 million in Q4 2025 for Bausch Health Companies, up from $1.0 million in the prior quarter.
Over the last five years, Asset Writedowns and Impairment for BHC hit a ceiling of $148.0 million in Q1 2021 and a floor of $1.0 million in Q3 2022.
Historically, Asset Writedowns and Impairment has averaged $22.7 million across 5 years, with a median of $8.0 million in 2022.
Biggest five-year swings in Asset Writedowns and Impairment: surged 4600.0% in 2021 and later crashed 94.59% in 2022.
Tracing BHC's Asset Writedowns and Impairment over 5 years: stood at $21.0 million in 2021, then crashed by 95.24% to $1.0 million in 2022, then soared by 300.0% to $4.0 million in 2023, then surged by 475.0% to $23.0 million in 2024, then plummeted by 69.57% to $7.0 million in 2025.
Business Quant data shows Asset Writedowns and Impairment for BHC at $7.0 million in Q4 2025, $1.0 million in Q3 2025, and $23.0 million in Q4 2024.